284 completed, 168 recruiting, 105 terminated, 104 unknown. 754 Phase 1, 200 Phase 2.
Follow Solid Tumor: new trials by email Literature Review of Solid Tumor trials Research Report on Solid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276 4SCAR-276 - Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 100 | 2027-06-01 | 2026-11-02 |
| A Phase 1/2 Trial Of Larotrectinib And Pembrolizumab In Patients With Solid Tumors Previously Treated With Immune Checkpoint Inhibitor Monotherapy Larotrectinib, Pembrolizumab - Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 22 | 2027-03-01 | 2026-09-28 |
| Intratumoral Chlorine Dioxide Injection in Advanced Solid Tumors Chlorine Dioxide Injection 2% - Solid Tumor, Neoplasms | Phase 1 | Not yet recruiting | SunGlow Innovations LLC | 50 | 2027-03-01 | 2026-11-02 |
| GD2/PSMA Bi-specific CAR-T Cell Therapy bi-4SCAR GD2/PSMA T cells - Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 60 | 2026-12-31 | 2026-11-02 |
| Study on GD2 Positive Solid Tumors by 4SCAR-GD2 4SCAR-GD2 - Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2026-12-31 | 2026-10-30 |
| An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid Tumors BON-106 - Solid Tumor, Advanced Solid Tumor | Phase 1 | Not yet recruiting | BeOne Medicines | 96 | 2026-12-01 | 2026-10-26 |
| SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET [225Ac]Ac-FL-261 - Solid Tumor, NSCLC | Phase 1 / Phase 2 | Recruiting | Full-Life Technologies UK Limited | 208 | 2026-12-01 | 2026-11-16 |
| A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors BM230 & PD-1 inhibitor - Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | Suzhou Biomissile Pharmaceuticals Co., Ltd. | 90 | 2026-11-01 | 2026-10-09 |
| A Study of HRS-8046 in Patients With Advanced Solid Tumors: Safety, Tolerability, and Pharmacokinetics HRS-8046 Tablet - Solid Tumor | Phase 1 | Not yet recruiting | Chengdu Suncadia Medicine Co., Ltd. | 175 | 2026-11-01 | 2026-11-16 |
| A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-9308 Tablet as Monotherapy or Combination Therapy in Participants With Advanced Solid Tumors HRS-9308 Tablet - Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | Chengdu Suncadia Medicine Co., Ltd. | 126 | 2026-11-01 | 2026-11-16 |
| A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors Tagmokitug, Pasritamig - Solid Tumor | Phase 1 / Phase 2 | Recruiting | Coherus Oncology, Inc. | 12 | 2026-11-01 | 2026-11-18 |
| A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics SHR-4595 for Injection - Solid Tumor | Phase 1 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 208 | 2026-10-20 | 2026-11-02 |
| A Study of DS-3939a in Participants With Solid Tumors DS-3939a, Pembrolizumab, Carboplatin - Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Daiichi Sankyo | 400 | 2026-10-13 | 2026-11-10 |
| Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations ASKC189 - Solid Tumor, RAS Mutation | Phase 1 | Not yet recruiting | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 200 | 2026-09-30 | 2026-09-23 |
| Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer Canagliflozin - Solid Tumor, SGLT 2 Inhibitors | Phase 1 | Recruiting | West China Hospital | 15 | 2026-09-10 | 2026-09-09 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors SI-B036 - Breast Cancer, Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 39 | 2026-08-18 | 2026-09-10 |
| A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors SHR-4685 - Solid Tumor | Phase 1 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 170 | 2026-08-13 | 2026-10-05 |
| A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors TJ037130 - Solid Tumor, Metastatic Ovary Cancer | Phase 1 | Recruiting | TJ Biopharma Co., Ltd. | 128 | 2026-08-05 | 2026-10-30 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors SI-B036 - Gastrointestinal Tumor, Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 10 | 2026-07-30 | 2026-09-04 |
| A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors GS-1206 - Solid Tumor | Phase 1 | Recruiting | Gilead Sciences | 302 | 2026-07-17 | 2026-11-04 |
Showing 20 of 754. Sign in to see all of them.
Neoplasms (100) · Neoplasm Metastasis (86) · Carcinoma, Non-Small-Cell Lung (78) · Colorectal Neoplasms (65) · Breast Neoplasms (57) · Melanoma (46) · Stomach Neoplasms (45) · Lymphoma (41) · Ovarian Neoplasms (41) · Pancreatic Neoplasms (40) · Squamous Cell Carcinoma of Head and Neck (31) · Carcinoma, Renal Cell (27) · Endometrial Neoplasms (27) · Lung Neoplasms (27) · Prostatic Neoplasms (23)
Neoplasms (318) · Neoplasms by Site (283) · Neoplasms by Histologic Type (198) · Digestive System Diseases (140) · Digestive System Neoplasms (137) · Neoplasms, Glandular and Epithelial (117) · Gastrointestinal Diseases (113) · Skin Diseases (111) · Skin and Connective Tissue Diseases (111) · Lung Diseases (108) · Respiratory Tract Diseases (108) · Gastrointestinal Neoplasms (107) · Thoracic Neoplasms (106) · Respiratory Tract Neoplasms (105) · Pathological Conditions, Signs and Symptoms (102)
pembrolizumab (60) · Nivolumab (34) · Paclitaxel (24) · Gemcitabine (23) · Cisplatin (22) · Docetaxel (19) · Capecitabine (17) · Injections (16) · Bevacizumab (14) · Carboplatin (13) · Cyclophosphamide (13) · Fluorouracil (13) · Irinotecan (12) · 130-nm albumin-bound paclitaxel (11) · atezolizumab (11)
Sichuan Baili Pharmaceutical Co., Ltd. (22) · Eli Lilly and Company (16) · Jiangsu HengRui Medicine Co., Ltd. (13) · M.D. Anderson Cancer Center (11) · Chinese PLA General Hospital (9) · Genentech, Inc. (9) · Impact Therapeutics, Inc. (9) · Merck Sharp & Dohme LLC (9) · Athenex, Inc. (6) · Bristol-Myers Squibb (6) · Hoffmann-La Roche (6) · Innovent Biologics (Suzhou) Co. Ltd. (6) · Memorial Sloan Kettering Cancer Center (6) · Astellas Pharma Inc (5) · Betta Pharmaceuticals Co., Ltd. (5)
United States (381) · China (234) · Spain (55) · South Korea (54) · Australia (51) · France (48) · United Kingdom (39) · Japan (38) · Canada (33) · Belgium (21) · Taiwan (21) · Netherlands (19) · Italy (16) · Germany (15) · Israel (12)
David Cutler, MD (5) · Jian Zhang (4) · Chuanling Li (3) · Jian Zhang, Doctor (3) · Jin Li (3)
PMID 38172595, PMID 29505699, PMID 35101941, PMID 37082579, PMID 37592303, PMID 42413526, PMID 42636835, PMID 18463792, PMID 19139178, PMID 20305636, PMID 21810918, PMID 22382879, PMID 22415795, PMID 23615181, PMID 24173967, PMID 24349470, PMID 24477603, PMID 24523121, PMID 24819685, PMID 25086465, PMID 25380636, PMID 26172205, PMID 26222558, PMID 26390038, PMID 26942463, PMID 26966027, PMID 26984449, PMID 27000274, PMID 27053773, PMID 27138582, PMID 27157491, PMID 27240885, PMID 27247226, PMID 27565932, PMID 27627808, PMID 27646946, PMID 27871319, PMID 28081914, PMID 28196905, PMID 28291584, PMID 28387632, PMID 28453692, PMID 28465370, PMID 28489510, PMID 28630120, PMID 28813164, PMID 28837405, PMID 28972963, PMID 29095678, PMID 29116900
2023 (12), 2018 (8), 2015 (6), 2016 (6), 2019 (6), 2014 (4), 2017 (3), 2008 (2), 2025 (1), P01CA111412 (1), R01CA266666 (1), R01MH115043 (1), R44CA265656 (1)